Hayfin Capital Management
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Hayfin Capital Management is an independent investment firm that offers lending solutions to European middle-market companies.
Investor Profile
Hayfin Capital Management has backed more than 15 startups, with 4 new investments in the last 12 months alone. The firm has led 10 rounds, about 67% of its total and boasts 7 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Debt Financing, Post Ipo Debt rounds (top funding stages).
- Majority of deals are located in United States, Ireland, Germany.
- Strong thematic focus on Health Care, Medical, Biotechnology.
- Led 2 rounds in the past year.
Stage Focus
- Series Unknown (27%)
- Debt Financing (27%)
- Post Ipo Debt (27%)
- Series F (7%)
- Convertible Note (7%)
- Private Equity (7%)
Country Focus
- United States (73%)
- Ireland (7%)
'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
- Germany (7%)
- Canada (7%)
- France (7%)
Industry Focus
- Health Care
- Medical
- Biotechnology
- Medical Device
- Pharmaceutical
- Therapeutics
- Artificial Intelligence (Ai)
- Health Diagnostics
- Financial Services
- Fintech
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
